Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression

Abstract Background This study aimed to uncover the key hepatitis-B (HB)-related liver cancer (LC) promoting genes, and clarity their interrelationships, enrichments, impacts on LC immune infiltration, and potential drugs targeting these genes. Methods The LC-survival associated genes were acquired...

Full description

Saved in:
Bibliographic Details
Main Authors: Liqin Ruan, Ningbo Fang, Xinhua Zhao, Weili Chen, Zhaoping Wu, Xiaoyong Wu
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Discover Oncology
Subjects:
Hepatitis B virus
Liver cancer
Hepatocellular carcinoma
Survival
Bioinformatics
Online Access:https://doi.org/10.1007/s12672-025-01851-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-01851-6

Similar Items